前收市價 | 8.46 |
開市 | 9.12 |
買盤 | 0.00 x 0 |
賣出價 | 0.00 x 0 |
今日波幅 | 8.46 - 8.46 |
52 週波幅 | 7.46 - 15.80 |
成交量 | |
平均成交量 | 2,929 |
市值 | 5.45B |
Beta 值 (5 年,每月) | 0.67 |
市盈率 (最近 12 個月) | 84.60 |
每股盈利 (最近 12 個月) | 0.10 |
業績公佈日 | 無 |
遠期股息及收益率 | 無 (無) |
除息日 | 2021年6月03日 |
1 年預測目標價 | 無 |
(Bloomberg) -- Grifols SA shares dropped as investors evaluated a regulatory review of the Spanish bio-science company’s financial reports, which found “relevant deficiencies” but no major accounting mistakes.Most Read from BloombergNY Gears Up to Seize Trump Westchester Assets If Fraud Fine Is UnpaidBaltimore Wants to Sell Hundreds of Vacant Homes for $1 EachWhat Happens If Trump Can’t Post His $454 Million BondChina Scrutinizes PwC Role in $78 Billion Evergrande Fraud CaseYemen’s Houthis Tell
Europe's main stock indices were flat on Friday, but notched strong gains over the week that saw record highs from German and French shares, while investors also analysed a U.S. jobs report for clues on the global monetary policy outlook. Technology lost 1.6% after BE Semiconductor slumped 16.1% on a media report that Joint Electron Device Engineering Council lowered certain chip standards which might delay investments into hybrid bonding technology.
Grifols SA (NASDAQ:GRFS) shares are down on Wednesday following the publication of a new report by Gotham City Research questioning the company’s “transparency, integrity and ethical conduct.” Grifols had previously denied Gotham City’s accusations, as per its February SEC filing, saying it had already replied to all of the questions raised in the latter’s reports. Grifols claimed in its public February 20 response that the company had addressed all our questions, yet new information from the Ke